Probiotics; Microbial therapy for health modulation

Defence Science Journal

Volumn 56, Issue 4, 2006, Pages 513-529

  Goel, Ajay Kumar ^a   Dilbaghi, N ^b   Kamboj, Dev Vrat ^a   Singh, Lokendra ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Gut health; Gut microflora; Health modulation; Human health; Microbial ecosystem; Microbial therapy; Prebiotics; Probiotics

Indexed keywords

BACTERIA; DRUG THERAPY; ECOSYSTEMS; HEALTH CARE; METABOLISM;

GUT HEALTH; GUT MICROFLORA; HEALTH MODULATION; HUMAN HEALTH; MICROBIAL ECOSYSTEM; MICROBIAL THERAPY; PREBIOTICS; PROBIOTICS;

MICROBIOLOGY;

EID: 33751048816     PISSN: 0011748X     EISSN: None     Source Type: Journal    
DOI: 10.14429/dsj.56.1917     Document Type: Review

References (120)

1. Isolauri, E.; Salminen, S.J. & Mattila-Sandholm, T. New functional foods in the treatment of food allergy. Annals of Medicine, 1999, 31, 299-02.
2. Salminen, S.; Bouley, C.; Boutron-Rualt, M.C.; Cummings, J.H.; Franck, A.; Gibson, G.R.; Isolauri, E.; Moreau, M.C.; Roberfroid, M. & Rowland, I. Functional food science and gastrointestinal physiology and function: The role of prebiotics and probiotics. Br. J. Nutr., 1998, 80, 147-71.
3. Lilly, D.M. & Stillwell, R.H. Probiotics, growth promoting factors produced by microorganisms. Science, 1965, 147, 747-48.
4. Bottazzi, V. Food and feed production with microorganisms. Biotechnology, 1983, S, 315-63.
5. Metchnikoff, E. The prolongation of life, optimistic studies. Butterworth-Heinemann, London, 1907.
6. Parker, R.B. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health, 1974, 29, 4-8.
7. Fuller, R. Probiotics in man and animals. J. Appl. Bacterial., 1989, 66, 365-78.
8. Havenaar, R. & Huis In't Veld, M.J.H. Probiotics: A general view. In Lactic acid bacteria in health and disease. Elsevier Applied Science Publishers, Amsterdam, 1992.
9. Salminen, S.; Ouwehand, A.; Benno, Y. & Lee, Y.K. Probiotics: How should they be defined? Trends Food Sci. Technol., 1999, 10, 107-10.
10. Schrezenmeir, J. & de Vrese, M. Probiotics, prebiotics and synbiotics-approaching a definition. Am. J. Clin. Nutr., 2001, 73, 361S-64S.
11. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30' and May 1, 2002.
12. Finegold, S.M.; Attebery, H.R. & Sutter, V.L. Effect of diet on human fecal flora: Comparison of Japanese and American diets. Am. J. Clin. Nutr., 1974, 27, 1546-569.
13. Dunne, C. Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder. Inflam. Bowel Dis., 2001, 7, 136-45.
14. Tancrede, C. Role of human microflora in health and disease. Eur. J. Clin. Microbiol. Infect. Dis., 1992, 11, 1012-015.
15. Moore, W.E.C. & Holdeman, L.V. Discussion of current bacteriological investigations of relationships between intestinal flora, diet, and colon cancer. Cancer Research, 1975, 35, 3418-420.
16. Travis, J. The bacteria in your intestines are welcome guests. Science News, 2003, 163, 344.
17. Gibson, G.R.; Wynne, A. & Bird, A. Microflora of the intestine: Role and effects. In Encyclopedia of human nutrition, edited by M. Sadler, J.J Strain, & B. Caballero. Academic Press, San Diego, 1998. pp. 1282-289.
18. Drasar, B. S. The bacterial flora of the stomach and small intestine. Gastroenterol. Clin. Biol., 1989, 13, 18-20.
19. Mitsuoka, T. The human gastrointestinal tract. In The lactic acid bacteria in health and disease, Vol. 1, edited by B.J.B. Wood. Elsevier Science Publishers, Ltd, Essex, England. 1992. pp. 69-114.
20. English, J. & Dean, W. Lactobacillus GG: New breakthrough probiotic clinically proven to support gastrointestinal health. Vit. Res. Nutr. News, June 1998.
21. Ishibashi, N & Yamazaki, S. Probiotics and safety. Am J. Clin. Nutr., 2001, 73, 465S-70S.
22. Carol, M.; Lambrechts, A.; Van Gossum, A.; Libin, M.; Goldman, M. & Mascart-Lemone, F. Spontaneous secretion of interferon-and interleukin-4 by human intraepithelial and lamina propria gut lymphocytes. Gut, 1998, 42, 643-49.
23. Isolauri, E. Probiotics in human disease. Am. J. Clin. Nutr., 2001, 73, 1142S-146S.
24. Simmering, R. & Blaut, M. Pro- and prebioticsthe tasty guardian angels? Appl. Microbiol. Biotechnol., 2001, 55, 19-28.
25. Shornikova, A.V.; Casas, I.A.; Isolauri, E. Mykkanen, H. & Vesikari, T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr., 1997, 24, 399-04.
26. Mitra, A.K. & Rabbani, G.H. A double-blind, controlled trial of bioflorin (Strptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli. Gastroenterology, 1990, 99, 1149-152.
27. Majamaa, M.; Isolauri, E.; Saxelin, M. & Vesikari, T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gstroenterol. Nutr., 1995, 20, 333-38.
28. Hilton, E.; Kolakowski, P.; Singer, C. & Smith, M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J. Travel. Med., 1997, 4, 41-43.
29. Markwalder, K. Traveler's diarrhea. Ther. Umsch., 2001, 58, 367-71.
30. Elmer, G.W. Probiotics: Living drugs. Am. J. Health Syst. Pharm., 2001, 58, 1101-109.
31. Bergogne-Berezin, E. Treatment and prevention of antibiotic-associated diarrhea. Int. J. Antimicrob. Agents, 2000, 16, 521-26.
32. Bartlett, J.G. Antibiotic-associated diarrhea. Clin. Infect. Dis., 1992, 15, 573-81.
33. McFarland, L.V.; Surawicz, C.M.; Greenberg, R.N.; Elmer, G.W.; Moyer, K.A.; Melcher, S.A.; Bowen, K.E. & Cox, J.L. Prevention of β-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol., 1995, 90, 439-48.
34. Saavedra, J.M.; Bauman, N.A.; Oung, I.; Perman, J.A. & Yolken, R.H. Feeding of Bifidobacterium bifidum and Enterococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet, 1994, 344, 1046-049.
35. Johnson, J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev., 1991, 4, 80-128.
36. Spiegel, C.A. Bacterial vaginosis. Clin. Microbiol. Rev., 1991, 4, 485-02.
37. Reid, G. & Bruce, A.W. Could probiotics be an option for treating and preventing urogenital infections? Medscape Womens Health, 2001, 6, 9.
38. Reid, G. Probiotic therapy and functional foods for prevention of urinary tract infections: State-of-the-art and science. Curr. Infect. Dis. Rep., 2000, 2, 518-22.
39. Hillier, S.L.; Krohn, M.A.; Klebanoff, S.J. & Eschenbach, D. A. The relationship of hydrogen peroxide producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol, 1992, 79, 369-73.
40. Sweet, R.L. New approaches for the treatment of bacterial vaginosis. Am. J. Obst. Gynecol., 1993, 169, 479-82.
41. Reid, G. & Bocking, A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am. J. Obstet. Gynecol., 2003, 189, 1202-208.
42. Skarin, A. & Sylwan, J. Vaginal lactobacilli inhibiting growth of Gardnerella vaginalis, Mobiluncus, and other bacterial species cultured from vaginal content of women with bacterial vaginosis. Acta Pathol. Microbiol. Immunol., 1986, 94, 399-03.
43. Famularo, G.; Pieluigy, M.; Coccia, R.; Mastroiacovo, P. & De Simone, C. Microecology, bacterial vaginosis, and probiotics: Perspectives for bacteriotherapy. Med. Hypotheses, 2001, 56, 421-30.
44. Famularo, G.; Mosca, L.; Minisola, G.; Trinchieri, V. & De Simone, C. Probiotic lactobacilli: A new perspective for the treatment of inflammatory bowel disease. Curr. Pharm. Des., 2003, 9, 1973-980.
45. Hamilton-Miller, J.M. Immunopharmacology of antibiotics: Direct and indirect immunomodulation of defence mechanisms. Journal of Chemotherapy, 2001, 13, 107-11.
46. Kwon, J. & Farrell, R. Probiotics and inflammatory bowel disease. Bio Drugs, 2003, 17, 179-86.
47. Gionchetti, P.; Amadini, C.; Rizzello, C.; Venturi, A.; Palmonari, V.; Morselli, C.; Romagnoli, R. & Campieri, M. Probiotics-role in inflammatory bowel disease. Dig. Liver Dis., 2002, 34, 58-62.
48. Hart, A.L.; Stagg, A.J. & Kamm, M.A. Use of probiotics in the treatment of inflammatory bowel disease. J. Clin. Gastroenterol., 2003, 36, 111-19.
49. Floch, M.H. Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr. Treat. Options Gastroenterol., 2003, 6, 283-88.
50. Kalliomaki, M.; Salminen, S.; Poussa, T.; Arvilommi, H. & Isolauri, E. Probiotics and prevention of atopic disease: 4-year followup of a randomised placebo-controlled trial. Lancet, 2003, 361, 1869-871.
51. Kirjavainen, P.V.; Salminen, S.J. & Isolauri, E. Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability. J. Pediatr. Gstroenterol. Nutr., 2003, 36, 223-27.
52. Isolauri, E.; Arvola, T.; Sutas, Y.; Moilanen, E. & Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy, 2000, 30, 1604-610.
53. Mayes, P.A. Cholesterol synthesis, transport and excretion. In Harper's Biochemistry, Ed. 22, edited by D.K. Granner, P.A. Mayes, V.W. Rodwell. Prentice Hall International Inc, London, 1998. pp. 249-60.
54. Lutton, C. The role of digestive tract in cholesterol metabolism. Digestion, 1976, 14, 342-56.
55. Field, F.J.; Kam, N.T.P. & Mathur, S.N. Regulation of cholesterol metabolism in the intestine. Gastroenterology, 1990, 99, 539-51.
56. Hasler, C.M. Functional foods: Their role in disease prevention and health promotion. Food Technology, 1998, 52, 63-70.
57. Sanders, M.E. Considerations for use of probiotics bacteria to modulate human health. Journal of Nutrition, 2000, 130, 384S-90S.
58. Hata, Y.; Yamamoto, M.; Ohni, M.; Nakajima, K.; Nakamura, Y. & Takano, T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr., 1996, 64, 767-71.
59. Sawada, H.; Furushiro, M.; Hirai, K.; Motoike, M.; Watanabe, T. & Yokokura, T. Purification and characterisation of an antihypertensive compound from Lactobacillus casei. Agric. Biol. Chem., 1990, 54, 3211-219.
60. Takano, T. Milk-derived peptides and hypertension reduction. Int. Dairy J., 1998, 8, 375-81.
61. Aso, Y.; Akazan, H.; Kotake, T.; Tsukamoto, T. & Imai, K. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur. Urol., 1995, 27, 104-19.
62. Singh, J.; Rivenson, A.; Tomita, M.; Shimamura, S.; Ishibashi, N. & Reddy, B.S. Bifldobacterium longum, a lactic acid-producing intestinal microflora inhibit colon cancer and modulate the intermediate biomarkers of colon carcinogenesis. Carcinogenesis, 1997, 18, 1371-377.
63. Reddy, B.S. & Rivenson, A. Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazol-(4,4-f) quinine, a food mutagen. Cancer Research, 1993, 53, 3914-918.
64. Femina, A.P.; Luceri, C.; Dolara, P.; Giannini, A.; Biggeh, A.; Salvadori, M.; Clune, Y.; Collins, K.J.; Peglierani, M. & Cademi, G. Anticarcinogenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnose and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis, 2002, 23, 1953-960.
65. Morelli, L. In vitro selection of probiotic lactobacilli: a critical appraisal. Curr. Issues Intest. Microbiol., 2000, 1, 59-67.
66. Dunne, C.; O'Mahony, L.; Murphy, L.; O'Halloran, S.; Feeney, M.; Flynn, S.; Fitzgerald, G.; Daly, C.; Kiely, B.; O'Sullivan, G.; Shanahan, F. & Collins, J.K. Probiotics; from myth to realityDemonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek, 1999, 76, 279-92.
67. Heyman, M.; Corthier, G.; Petit, A.; Meslin, J.C.; Moreau, C. & Desjeux, J.F. Intestinal absorption of macromolecules during viral enteritis: An experimental study on rotavirus-infected conventional and germ-free mice. Pediatric Research, 1987, 22, 72-78.
68. Mital, B.K. & Garg, S.K. Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus. Crit. Rev. Microbiol., 1995, 21, 175-14.
69. Bogovic-Matijasic, B.; Rogelj, I.; Nes, I.F. & Holo, H. Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221. Appl. Microbiol. Biotechnol., 1998, 49, 606-12.
70. Pathak, D.V.; Kumar, R.; Goel, A.K. & Dadarwal, K.R. Bacteriocins from gram-negative bacteria. Indian J. Microbiol., 1998, 38, 53-62.
71. Goel, A.K.; Sindhu, S.S. & Dadarwal, K.R. Bacteriocin producing native rhizobia of green gram (Vigna radiat a) having competitive advantage in nodule occupancy. Microbiological Research, 1999, 154, 43-48.
72. Bongaerts, G.P.A. & Severijnen, R.S.V.M. The beneficial, anti-microbial effect of probiotics. Medical Hypotheses, 2001, 56, 174-77.
73. Chow, J. Probiotics and prebiotics: A brief overview. J. Ren. Nutr., 2002, 12, 76-86.
74. Collington, G.K.; Parker, D.S. & Armstrong, D.G. The influence of inclusion of either an antibiotic or a probiotic in the diet on the development of digestive enzyme activity in the pig. Br. J. Nutr., 1990, 64, 59-70.
75. de Vrese, M.; Stegelmann, A.; Richter, B.; Fenselau, S.; Laue, C. & Schrezenmeir, J. Probiotics-compensation for lactase insufficiency. Am. J. Clin. Nutr., 2001, 73, 421S-9S.
76. Hond, E.D.; Hiele, M.; Evenepoel, P.; Peeters, M.; Ghoos, Y. & Rutgeerts, P. In vivo butyrate metabolism and colonic permeability in extensive colitis. Gastroenterology, 1998, 115, 584-590.
77. Arakil, Y.; Andoh, A.; Fujiyama, Y.; Takizawal, J.; Takizawal, W. & Bamba, T. Oral administration of a product derived from Clostridium butyricum in rats. Int. J. Mol. Med., 2002, 9, 53-57.
78. Kanauchi, O.; Fujiyama, Y.; Mitsuyama, K.; Araki, Y.; Ishii, T.; Nakamura, T.; Hitomi, Y.; Agata, K.; Saiki, T.; Andoh, A.; Toyonaga, A. & Bamba, T. Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int. J. Mol. Med., 1999, 3, 175-79.
79. Cummings, J.H. & Macfarlane, G.T. Role of intestinal bacteria in nutrient metabolism. J. Parenteral. Enteral. Nutr., 1997, 21, 357-65.
80. Lopez, H.W.; Coudray, C.; Bellanger, J.; Younes, H.; Demigne, C. & Remesy, C. Intestinal fermentation lessens the inhibitory effects of phytic acid on mineral utilization in rats. Journal of Nutrition, 1998, 128, 1192-198.
81. Hosono, A.; Otani, H.; Yasui, H. & Watanuki, M. Impact of fermented milk on human health: Cholesterol-lowering and immunomodulatory properties of fermented milk. Animal Sci. J., 2002, 73, 241-56.
82. McCrackon, V.J. & Gaskins, H.R. In Probiotics: A critical review, edited by G.W. Tannock. Horizon Scientific Press, Norfolk, UK, 1999. pp. 85-111.
83. Herias, M.V.; Hessle, C.; Telemo, E.; Midtvedt, T.; Hanson, L.A. & Wold, A.E. Immunomodulatory effects of Lactobacillus plantarum colonising the intestine of gnotobiotic rats. Clin. Exp. Immunol., 1999, 116, 283-90.
84. Kirjavainen, P.V.; ElNezami, H.S.; Salminen, S.J.; Ahokas, J.T. & Wright, P.F.A. Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii sub sp. shermanii JS on mouse lymphocyte proliferation. Clin. Diagn. Lab. Immunol., 1999, 6, 799-02.
85. Mike, A.; Nagaoka, N.; Tagami, Y.; Miyashita, M.; Shimada, S.; Uchida, K.; Nanno, M. & Ohwaki, M. Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice. Clin. Exp. Immunol., 1999, 117, 368-75.
86. Pessi, T.; Sutas, Y.; Hurme, M. & Isolauri, E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy, 2000, 30, 1804-808.
87. Sewankambo, N. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet, 1997, 350, 546-50.
88. Martinez, F.D. & Holt, P.O. Role of microbial burden in aetiology of allergy and asthma. Lancet, 1999, 354, 12-15.
89. Majamaa, H. & Isolauri, E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol., 1997, 99, 179-85.
90. Sudo, N.; Sawamura, S.; Tanaka, K.; Aiba, Y.; Kubo, C. & Koga, Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. Journal of Immunology, 1997, 159, 1739-745.
91. Gaskins, H.R. Immunological aspects of host/ microbiota interactions at the intestinal epithelium. In Gastrointestinal microbiology, edited by R.I. Mackie, B.A. White & R.E. Isaacson. International Thomson Publishing, New York, 1997. pp. 537-87.
92. Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P. & Isolauri, E. Probiotics in primary prevention of atopic disease. Lancet, 2001, 357, 1076-079.
93. Ling, W.H.;Korpela, R.;Mykkanen, H.; Salminen, S. & Hanninen, O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. Journal of Nutrition, 1994, 124, 18-23.
94. Orrhage, K.; Silierstrom, E.; Gustafsson, J.A.; Nord, C.E. & Rafter, J. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutation Research, 1994, 311, 239-48.
95. Donaldson, R.(Jr) Normal bacterial populations of the intestine and their relation to intestinal function. N. Eng. J. Med., 1964, 270, 904-99.
96. Mattar, A.F.; Drongowski, R.A.; Coran, A.G. & Harmon, C.M. Effect of probiotics on enterocyte translpcation in vitro. Pediatr. Surg. Int., 2001, 17, 265-68.
97. Gilliland, S.E.; Nelson, C.R. & Maxwell, C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol., 1985, 49, 377-81.
98. Tahri, K.; Ballongue, J. & Schneider, F. Effects of three strains of Bifidobacteria on cholesterol. Lett. Appl. Microbiol., 1995, 21, 149-51.
99. Charteris, W.P.; Kelly, P.M.; Morelli, L. & Collins, J.K. Selective detection, enumeration and identification of potentially probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations. Int. J. Food Microbiol., 1997, 35, 1-27.
100. Woese, C.R. Bacterial evolution. Microbiolics Reviews, 1987, 51, 221-71.
101. Vaughan, E.E.; Heilig, H.G.H.J.; Zoetendal, E.G.; Satokari, R.; Collins, J.K.; Akkermans, A.D.L. & de Vos, W.M. Molecular approaches to study probiotic bacteria. Trends Food Sci. Technol., 1999, 10, 400-04.
102. Duffner, F. & O'Connell, M. Comparative evaluation of plasmid profiling and ribotyping in the analysis of Lactobacillus plantarum strain heterogeneity in silage. J. Appl. Bacteriol., 1995, 78, 20-27.
103. Holzapfel, W.H.; Haberer, P.; Geisen, R.; Björkroth, J. & Schillinger, U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr., 2001, 73, 365S-73S.
104. Ahme, S. & Molin, G. Restriction endonuclease analysis of total chromosomal DNA of Lactobacillus. Microecology Ther., 1997, 26, 27-30.
105. Stahl, M. & Molin, G. Classification of Lactobacillus reuteri by restriction endonuclease analysis of chromosomal DNA. Int. J. Syst. Bacterial., 1994, 44, 9-14.
106. Jansen, G.J.; Wildeboer-Veloo, A.C.; Tonk, R.H.; Frank, A.H. & Welling, G.W. Development and validation of an automated microscopy-based method for enumeration of groups of intestinal bacteria. J. Microbiol. Method., 1999, 37, 215-21.
107. Drouault, S.; Corthier, G.; Ehrlich, S.D. & Renault, P. Survival, physiology and lysis of Lactobacillus lactis in the digestive tract. Appl. Environ. Microbiol., 1999, 66, 383-91.
108. Ishibashi, N. & Yamazaki, S. Probiotics and safety. Am. J. Clin. Nutr., 2001, 73, 465S-70S.
109. Saxelin, M.; Rautelin, H.; Salminen, S. & Mäkelä, P.H. The safety of commercial products with viable Lactobacillus strains. Infect. Dis. Clin. Pract., 1996, 5, 331-35.
110. Gasser, F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur., 1994, 92, 45-67.
111. Saarela, M.; Mogensen, G.; Fonden, R.; Matto, J. & Mattila-Sandholm, T. Probiotic bacteria: Safety, functional and technological properties. Journal of Biotechnology, 2000, 84, 197-15.
112. Bernardeau, M.; Vernoux, J.P. & Gueguen, M. Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice. Int. J. Food Microbiol., 2002, 77, 19-27.
113. Huang, Y.; Kotula, L. & Adams, M.C. The in vivo assessment of safety and gastrointestinal survival of an orally-administered novel probiotic, Propionibacterium jensenii 702, in a male Wistar rat model. Food Chem. Toxicol., 2003, 41, 1781-787.
114. Drasar, B.S. & Hill, M.J. In Human intestinal flora. Academic Press, London, 1974. pp. 72-102.
115. Araya-Kojima, T.; Yaeshima, T.; Ishibashi, N.; Shimamura, S. & Hayasawa, H. Inhibitory effects of Bifidobacterium longum BB536 on harmful intestinal bacteria. Bifidobacterium Microflora, 1995, 14, 59-66.
116. Ruseler-Van Embden, G.H.; Van Lieshout, L.M.C.; Gosselink, M.J. & Marteau, P. Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. Scand. J. Gastroenterol., 1995, 30, 675-80.
117. Chomarat, M. & Espinouse, D. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftrazidime-vancomycin. Eur. J. Clin. Microbiol. Infect. Dis., 1991, 10, 44.
118. Asahara, T.; Takahashi, M.; Nomoto, K.; Takayama, H.; Onoue, M.; Morotomi, M. Tanaka, R.; Yokokura, T. & Yamashita, N. Assessment of safety of Lactobacillus strains based on resistance to host innate defense mechanisms. Clin. Diagn. Laboratory Immunology, 2003, 10, 169-73.
119. Gibson G.R. & Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of probiotics. Journal of Nutrition, 1995, 125, 1401-412.
120. Marteau, P. & Boutron-Ruault, M.C, Nutritional advantages of probiotics and prebiotics. Brit. J. Nutr., 2002, 87, 153-57.